Combining Neratinib with CDK4/6, mTOR, and MEK Inhibitors in Models of HER2-positive Cancer
2021 · Clinical Cancer Research · 61 citations
https://doi.org/10.1158/1078-0432.ccr-20-3017
H
Heping Wang
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
52
Papers
503
Citations
11
h-index
14
i10-index
Heping Wang is an academic researcher from State Grid Corporation of China (China). The author has contributed to research in topics: Circadian rhythm and melatonin & Genetics, Aging, and Longevity in Model Organisms & Immune Cell Function and Interaction. The author has an h-index of 11, co-authored 45 publications.
ORCID: 0000-0001-9968-8658Papers by this author
worksCancer cell-expressed BTNL2 facilitates tumour immune escape via engagement with IL-17A-producing γδ T cells
2022 · Nature Communications · 35 citations
https://doi.org/10.1038/s41467-021-27936-8
Oral iron sulfide prevents acute alcohol intoxication by initiating the endogenous multienzymatic antioxidant defense system
2025 · Science Advances · 6 citations
https://doi.org/10.1126/sciadv.adr4231
One-Year Effectiveness Study of Intravitreously Administered Conbercept® Monotherapy in Diabetic Macular Degeneration: A Systematic Review and Meta-Analysis
2020 · Diabetes Therapy · 5 citations
https://doi.org/10.1007/s13300-020-00806-0
Modeling of lung organoid-based fibrosis for testing the sensitivity of anti-fibrotic drugs
2025 · Stem Cell Research & Therapy · 5 citations
https://doi.org/10.1186/s13287-025-04251-3
BAE-related Complications.
2015 · Figshare · 0 citations
https://doi.org/10.1371/journal.pone.0115956.t003
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat